1. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD
- Author
-
Lin Wang, Shan Wang, Da-Li Han, Wei Dong, Zong-Li Zhang, Hongliang Guo, Chao Xie, and Jie Chai
- Subjects
Gene knockdown ,Colorectal cancer ,Chemistry ,Clinical Biochemistry ,Endogeny ,Cell Biology ,Pharmacology ,medicine.disease ,Biochemistry ,digestive system diseases ,law.invention ,law ,Apoptosis ,Fluorouracil ,microRNA ,Genetics ,medicine ,Cancer research ,Suppressor ,DPYD ,Molecular Biology ,medicine.drug - Abstract
Chemoresistance of colon cancer cells to the chemotherapeutics is still a main obstacle in treatment of this malignancy. The microRNA (miRNA) mediated chemosensitivity regulation in colon cancer cells is still largely unknown. Here we constructed a fluorouracil (5-Fu) resistant SW480 cell line (SW480/5-Fu) and discovered that miRNA miR-494 was down-regulated in the drug resistant cells compared with the parental cells. miR-494 level was found to be correlated with 5-Fu sensitivity in colon cancer cells, and artificial alteration of miR-494 affects the sensitivity of colon cancer cell lines to 5-Fu. miR-494 also promoted apoptosis of colon cancer cells at present of 5-Fu. Importantly, as a regulatory enzyme in the 5-Fu catabolic pathway, DPYD was confirmed to be a direct target of miR-494 through the interaction of miR-494 and its binding site within DPYD 3' untranslated region (3'UTR). miR-494 also negatively regulated endogenous DPYD expression in SW480 cells. Overexpression or knockdown of DPYD could attenuate miR-494 mediated 5-Fu sensitivity regulation, suggesting the dependence of DPYD regulation in miR-494 activity. miR-494 inhibited SW480/5-Fu derived xenograft tumors growth in vivo at present of 5-Fu. Thus, we concluded that in colon cancer cells, tumor suppressor miR-494 enhanced 5-Fu sensitivity via regulation of DPYD expression.
- Published
- 2015
- Full Text
- View/download PDF